Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion type Assertion NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_head.
- NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion description "[Consequently, new genes have emerged as breast cancer susceptibility genes, including rare germline mutations in high penetrant genes, such as TP53 and PTEN, and more frequent mutations in moderate penetrant genes, such as CHEK2, ATM and PALB2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_provenance.
- NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion evidence source_evidence_literature NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_provenance.
- NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion SIO_000772 25467110 NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_provenance.
- NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion wasDerivedFrom befree-20150227 NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_provenance.
- NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_assertion wasGeneratedBy ECO_0000203 NP945337.RAbBsyOIy9PyGiebaMtM8OiAEzT-GbOsf_L0D5h45PxGA130_provenance.